Smartleaf Asset Management’s Guardian Pharmacy Services GRDN Stock Holding History

Smartleaf Asset Management’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$488	Buy	+12	New	+$489	﹤0.01%	3343

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Braun Stacey Associates New York $3.48B AUM 48.73% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return

Smartleaf Asset Management's GRDN Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Guardian Pharmacy Services (GRDN) in Q3 2026: 12 shares worth $488. The stake represents ﹤0.01% of the portfolio and ranks #3343 among its holdings.

88 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.

Smartleaf Asset Management held 12 shares of Guardian Pharmacy Services worth $488 as of Q3 2026.
Guardian Pharmacy Services was a new Smartleaf Asset Management position in Q3 2026.
Guardian Pharmacy Services made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3343 holding.
88 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.